Kelly Eppich - CREMETRSBI DL-001 Independent Director

All Insiders . Germany . 
Stock . CREMECOMTRSBI DL 001 . Stakeholders . Insider . Kelly Eppich
WY52 Stock  EUR 1.70  0.00  0.00%   

Insider

Kelly Eppich is Independent Director of CREMECOMTRSBI DL 001 since 2019.
Age 62
Tenure 6 years
Phone972-349-3200
Webhttp://www.cimcommercial.com

CREMETRSBI DL-001 Management Efficiency

The company has return on total asset (ROA) of 0.0151 % which means that it generated a profit of $0.0151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.014 %, meaning that it generated $0.014 on every $100 dollars invested by stockholders. CREMETRSBI DL-001's management efficiency ratios could be used to measure how well CREMETRSBI DL-001 manages its routine affairs as well as how well it operates its assets and liabilities.
CREMECOMTRSBI DL 001 has accumulated 260.72 M in total debt with debt to equity ratio (D/E) of 0.64, which is about average as compared to similar companies. CREMECOMTRSBI DL 001 has a current ratio of 7.13, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist CREMETRSBI DL-001 until it has trouble settling it off, either with new capital or with free cash flow. So, CREMETRSBI DL-001's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CREMECOMTRSBI DL 001 sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CREMETRSBI to invest in growth at high rates of return. When we think about CREMETRSBI DL-001's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Kent GriffinCOUSINS PTIES INC
49
Laura SesodyBoston Properties
N/A
MA MAGreat Portland Estates
54
Donna HylandCOUSINS PTIES INC
58
Pamela RoperCOUSINS PTIES INC
45
Dan MAGreat Portland Estates
N/A
Mortimer ZuckermanBoston Properties
85
Robert ChapmanCOUSINS PTIES INC
65
BSc BScGreat Portland Estates
N/A
Richard HicksonCOUSINS PTIES INC
44
ACA ACAGreat Portland Estates
49
Raymond RitcheyBoston Properties
72
Lillian GiornelliCOUSINS PTIES INC
58
Helen HanBoston Properties
N/A
Matthew BrownOffice Properties Income
41
Michael LaBelleBoston Properties
59
Carrie HeissGreat Portland Estates
N/A
Michael WalshBoston Properties
56
BA MAGreat Portland Estates
N/A
R StoneCOUSINS PTIES INC
65
Jeffrey SymesCOUSINS PTIES INC
53
CIM Commercial is a real estate investment trust that primarily acquires, owns, and operates Class A and creative office assets in vibrant and improving metropolitan communities throughout the United States . CIM Commercial is operated by affiliates of CIM Group, L.P., a vertically-integrated owner and operator of real assets with multi-disciplinary expertise and in-house research, acquisition, credit analysis, development, finance, leasing, and onsite property management capabilities. CIM COMM operates under REITOffice classification in Germany and is traded on Frankfurt Stock Exchange. It employs 4 people. CREMECOMTRSBI DL 001 (WY52) is traded on Frankfurt Exchange in Germany and employs 5 people.

Management Performance

Return On Equity0.014
Return On Asset0.0151

CREMECOMTRSBI DL 001 Leadership Team

Elected by the shareholders, the CREMETRSBI DL-001's board of directors comprises two types of representatives: CREMETRSBI DL-001 inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CREMETRSBI. The board's role is to monitor CREMETRSBI DL-001's management team and ensure that shareholders' interests are well served. CREMETRSBI DL-001's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CREMETRSBI DL-001's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jan Salit, President Secretary
Frank Golay, Independent Director
Avi Shemesh, Director
Avraham Shemesh, Director
David Thompson, Chief Executive Officer
Robert Cresci, Independent Director
Kelly Eppich, Independent Director
Douglas Bech, Independent Director
Richard Ressler, Chairman of the Board
Shaul Kuba, Director
Nathan DeBacker, Chief Financial Officer

CREMETRSBI Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CREMETRSBI DL-001 a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.014
Return On Asset0.0151
Profit Margin0.06 %
Operating Margin0.16 %
Shares Outstanding22.74 M
Shares Owned By Insiders13.49 %
Shares Owned By Institutions59.07 %
Price To Earning4.83 X
Revenue101.34 M
Gross Profit42.62 M

Currently Active Assets on Macroaxis

CRMSalesforce
CCitigroup
GMGeneral Motors
WDWalker Dunlop
MSFTMicrosoft

Other Information on Investing in CREMETRSBI Stock

CREMETRSBI DL-001 financial ratios help investors to determine whether CREMETRSBI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CREMETRSBI with respect to the benefits of owning CREMETRSBI DL-001 security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY